Atai Life Sciences Q4 Operating Expenses USD 571.048 Million

Reuters03-06

March 6 (Reuters) - AtaiBeckley Inc ::
*ATAI LIFE SCIENCES Q4 OPERATING EXPENSES USD 571.048 MILLION
*ATAI LIFE SCIENCES Q4 EPS USD -1.73
*ATAI LIFE SCIENCES Q4 OPERATING INCOME USD -569.982 MILLION
*ATAI LIFE SCIENCES Q4 PRETAX PROFIT USD -544.92 MILLION
*ATAIBECKLEY INC Q4 EPS $-1.73, REVENUE $1.1 MILLION

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 06-MAR-202612:00:00.65 GMT

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2617687707?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 20:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617687707","market":"us","top_or_hot":-1,"title":"Atai Life Sciences Q4 Operating Expenses USD 571.048 Million","media":"Reuters","content":"<html><body>March 6 (Reuters) - AtaiBeckley Inc <atai.o>::<br/>*ATAI LIFE SCIENCES Q4 OPERATING EXPENSES USD 571.048 MILLION<br/>*ATAI LIFE SCIENCES Q4 EPS USD -1.73<br/>*ATAI LIFE SCIENCES Q4 OPERATING INCOME USD -569.982 MILLION<br/>*ATAI LIFE SCIENCES Q4 PRETAX PROFIT USD -544.92 MILLION<br/>*ATAIBECKLEY INC Q4 EPS $-1.73, REVENUE $1.1 MILLION<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 06-MAR-202612:00:00.65 GMT</atai.o></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Atai Life Sciences Q4 Operating Expenses USD 571.048 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAtai Life Sciences Q4 Operating Expenses USD 571.048 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-06 20:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>March 6 (Reuters) - AtaiBeckley Inc <atai.o>::<br/>*ATAI LIFE SCIENCES Q4 OPERATING EXPENSES USD 571.048 MILLION<br/>*ATAI LIFE SCIENCES Q4 EPS USD -1.73<br/>*ATAI LIFE SCIENCES Q4 OPERATING INCOME USD -569.982 MILLION<br/>*ATAI LIFE SCIENCES Q4 PRETAX PROFIT USD -544.92 MILLION<br/>*ATAIBECKLEY INC Q4 EPS $-1.73, REVENUE $1.1 MILLION<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 06-MAR-202612:00:00.65 GMT</atai.o></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATAI","symbol_name":"Atai Beckley Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nRSD5Hn0RZ:1","article_id":"2617687707","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617687707","pubTimestamp":1772800612,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"March 6 (Reuters) - AtaiBeckley Inc ::*ATAI LIFE SCIENCES Q4 OPERATING EXPENSES USD 571.048 MILLION*ATAI LIFE SCIENCES Q4 EPS USD -1.73*ATAI LIFE SCIENCES Q4 OPERATING INCOME USD -569.982 MILLION*ATAI","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATAI":"Atai Beckley Inc","BK4007":"制药","BK4539":"次新股"},"translate_title":"Atai Life Sciences Q4运营费用57104.8万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATAI":0.9},"content_text":"March 6 (Reuters) - AtaiBeckley Inc ::*ATAI LIFE SCIENCES Q4 OPERATING EXPENSES USD 571.048 MILLION*ATAI LIFE SCIENCES Q4 EPS USD -1.73*ATAI LIFE SCIENCES Q4 OPERATING INCOME USD -569.982 MILLION*ATAI LIFE SCIENCES Q4 PRETAX PROFIT USD -544.92 MILLION*ATAIBECKLEY INC Q4 EPS $-1.73, REVENUE $1.1 MILLION  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-MAR-202612:00:00.65 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2617687707","isCrawlerRequest":true}